Segmentation by type classifies photoinitiators according to their mechanistic pathway, a distinction that shapes formulation strategy and cost structure. Type I (cleavage) initiators, such as benzoin ethers, undergo homolytic bond scission upon UV absorption, directly generating free radicals; they dominate the coatings and printing inks sub‑markets, accounting for roughly 55 % of total volume because of their high reactivity and relatively low concentration requirement. Type II (hydrogen‑abstraction) systems, exemplified by benzophenone paired with a co‑initiator, rely on a triplet‑state energy transfer and represent about 35 % of sales, favored in adhesives and electronics where deeper penetration and controlled cure depth are critical. Hybrid photoinitiators combine cleavage and abstraction functionalities, capturing niche demand in medical devices and high‑performance electronics, contributing an estimated 8 % share. The remaining 2 % comprises emerging visible‑light initiators that operate beyond the traditional UV band, currently limited to research‑driven prototypes. This type‑based market taxonomy clarifies how kinetic efficiency, wavelength compatibility, and regulatory compliance allocate revenue across the photoinitiator portfolio.
